Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Prev Med. 2013 Jun 27;57(4):377–385. doi: 10.1016/j.ypmed.2013.06.017

Table 4.

Hazard ratios for all-cause and cause specific mortality in relation to self-reported sleep duration among 73,749 women in the Multiethnic Cohort Study, 1993-2007a,b

Outcomec Deaths
Daily sleeping
≤5 hr
6 hr
7 hr
8 hr
≥9 hr
No. % HR (95% CI) HR (95% CI) HR HR (95% CI) HR (95% CI)
All Causes 8,597 - 1.14 (1.06-1.23)* 1.05 (0.99-1.12) 1.00 1.02 (0.96-1.08) 1.22 (1.13-1.31)*
    Malignant Neoplasms 3,055 35.5 1.10 (0.97-1.25) 1.03 (0.94-1.14) 1.00 0.97 (0.88-1.07) 0.99 (0.87-1.14)
    Cardiovascular disease 2,838 33.0 1.20 (1.05-1.36)* 1.06 (0.96-1.18) 1.00 1.08 (0.98-1.20) 1.29 (1.13-1.47)*
        Coronary Heart Disease 1,380 16.1 1.18 (0.98-1.42) 1.13 (0.97-1.31) 1.00 1.12 (0.96-1.29) 1.23 (1.02-1.49)*
            Myocardial Infarction 521 6.1 1.18 (0.87-1.59) 1.23 (0.96-1.56) 1.00 1.10 (0.86-1.40) 1.29 (0.94-1.75)
            Ischemic Heart Disease 859 10.0 1.18 (0.94-1.49) 1.06 (0.88-1.29) 1.00 1.13 (0.94-1.36) 1.20 (0.95-1.53)
        Stroke 632 7.4 1.16 (0.88-1.52) 0.99 (0.79-1.23) 1.00 1.07 (0.87-1.33) 1.39 (1.06-1.83)*
        Cardiomyopathy 89 1.0 --- --- --- --- ---
        Cardiac Arrest 88 1.0 --- --- --- --- ---
        Hypertensive Heart Disease 130 1.5 1.45 (0.81-2.58) 1.34 (0.81-2.20) 1.00 1.13 (0.67-1.89) 1.72 (0.95-3.09)
        Hypertension 106 1.2 2.21 (1.09-4.46)* 2.03 (1.11-3.72)* 1.00 2.05 (1.13-3.71)* 2.46 (1.22-4.97)*
    Respiratory disease 615 7.2 1.23 (0.92-1.65) 1.26 (1.00-1.58) 1.00 1.14 (0.91-1.43) 1.62 (1.25-2.11)*
        Pneumonia 213 2.5 0.87 (0.49-1.52) 1.45 (0.98-2.15) 1.00 1.45 (0.98-2.13) 2.08 (1.32-3.26)*
    All others 2,089 24.3 1.13 (0.97-1.31) 1.03 (0.91-1.16) 1.00 0.97 (0.86-1.10) 1.33 (1.15-1.55)*
        Infectious/Parasitic Disease 144 1.7 1.59 (0.94-2.71) 0.93 (0.58-1.51) 1.00 1.04 (0.66-1.66) 1.90 (1.11-3.26)*
        Diabetes 312 3.6 1.24 (0.84-1.84) 1.22 (0.87-1.69) 1.00 1.15 (0.83-1.59) 1.57 (1.09-2.28)*
        Mental/Behavioral Disease 120 1.4 0.92 (0.46-1.83) 1.33 (0.83-2.11) 1.00 0.93 (0.56-1.54) 0.90 (0.44-1.86)
        Alzheimer's Disease 155 1.8 0.93 (0.34-2.53) 0.98 (0.48-2.02) 1.00 1.36 (0.72-2.59) 1.70 (0.73-3.97)
        Parkinson's Disease 64 0.7 --- --- --- --- ---
        Liver Disease 122 1.4 1.55 (0.83-2.88) 1.20 (0.71-2.04) 1.00 1.29 (0.77-2.14) 1.97 (1.09-3.54)*
        Kidney Disease 106 1.2 0.71 (0.34-1.45) 0.73 (0.42-1.27) 1.00 0.92 (0.55-1.53) 1.36 (0.74-2.49)
        Accidents 155 1.8 0.74 (0.39-1.40) 1.10 (0.73-1.66) 1.00 0.86 (0.55-1.35) 1.41 (0.82-2.44)

Abbreviation: CI, Confidence Intervals; HR, Hazard Ratio.

*

HR (95% CI) which not includes 1.00

a

Hazard ratios were calculated with age as the time metric, adjusted for 5-year age groups at cohort entry, sex, ethnicity, education, marital status, history of hypertension or diabetes at enrollment, alcohol consumption, energy intake, body mass index, physical activity (METs per week for moderate activity, vigorous work and strenuous sports), hours spent daily watching television, and smoking history by inclusion of the following variables: [smoking status, average number of cigarettes, average number of cigarettes squared, number of years smoked (time dependent), number of years since quitting (time dependent), and interactions between ethnicity and the smoking variables].

b

The test of heterogeneity across causes of death was performed using competing risk techniques, where each cause was a different event. A Wald test was used to compare the parameters between causes. P for heterogeneity (degrees of freedom = 12) across malignant neoplasms, cardiovascular disease, respiratory disease, and all others was <0.01. P for heterogeneity (degrees of freedom = 32) across specific cardiovascular disease was 0.72. P for heterogeneity (degrees of freedom = 60) across cause-specific disease within ‘All others’ was 0.54.

c

Hazard ratios are given only for conditions with 100 cases or more.